Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A0NZ
|
|||
| Former ID |
DIB004884
|
|||
| Drug Name |
LP-02
|
|||
| Synonyms |
LT-02; Phosphatidylcholine (controlled release formulation, ulcerative colitis), Lipid Therapeutics
Click to Show/Hide
|
|||
| Indication | Ulcerative colitis [ICD-11: DD71; ICD-9: 556] | Phase 3 | [1] | |
| Company |
University of Heidelberg
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02280629) Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.